Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Unspecified Adult Solid Tumor, Protocol Specific 6Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Intraocular Lymphoma 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms, Male 2Advanced Solid Tumors 2Wilms Tumor 1Testicular Neoplasms 1

Interventions

Filgrastim 5Docetaxel 3Carboplatin 3Cyclosporine 2Cyclophosphamide 2sargramostim 1pegfilgrastim 1ixabepilone 1flt3 ligand protein 1eflapegrastim 1Topotecan 1Thrombopoietin 1Taxes 1Stem Cell Factor 1Phenobarbital 1Paclitaxel 1Oxaliplatin 1Mannose-Binding Lectin 1Leucovorin 1Lenalidomide 1Irinotecan 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Etoposide 1Epoetin Alfa 1Epirubicin 1EC regimen 1Doxorubicin 1Diet, High-Fat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neutropenia × ixabepilone × Clear all
NCT00020371 2024-03-04

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

National Cancer Institute (NCI)

Phase 1 Completed

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡